Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved

[1]  M. Danielsen,et al.  Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family. , 2006, Cancer genetics and cytogenetics.

[2]  M. Vieth,et al.  Cytokeratin 7/20 and mucin core protein expression in ulcerative colitis-associated colorectal neoplasms , 2006, Virchows Archiv.

[3]  C. N. Leitão,et al.  Gastric and intestinal differentiation in Barrett's metaplasia and associated adenocarcinoma. , 2005, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus.

[4]  S. Kawauchi,et al.  Two subtypes of mucinous colorectal carcinoma characterized by laser scanning cytometry and comparative genomic hybridization. , 2004, International journal of oncology.

[5]  J. Soares,et al.  Losses of Heterozygosity on Chromosomes 9p and 17p Are Frequent Events in Barrett’s Metaplasia Not Associated With Dysplasia or Adenocarcinoma , 2003, American Journal of Gastroenterology.

[6]  G. Casey,et al.  Diffuse Large B-Cell Lymphoma of the Stomach: Assessment of Microsatellite Instability, Allelic Imbalance, and Trisomy of Chromosomes 3, 12, and 18 , 2002, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[7]  Patricia L. Blount,et al.  p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. , 2001, Cancer research.

[8]  M. Copin,et al.  Mucin gene expression in intestinal epithelial cells in Crohn's disease , 2001, Gut.

[9]  M. Sales,et al.  Chromosomal imbalances in gastric and esophageal adenocarcinoma: Specific comparative genomic hybridization–detected abnormalities segregate with junctional adenocarcinomas , 2001, Genes, chromosomes & cancer.

[10]  J. Flejou,et al.  Chromosomal numerical aberrations are frequent in oesophageal and gastric adenocarcinomas: a study using in‐situ hybridization , 2000, Histopathology.

[11]  Carissa A. Sanchez,et al.  Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. , 2000, Journal of the National Cancer Institute.

[12]  A. Zelenetz,et al.  MUC1 dysregulation as the consequence of a t(1;14)(q21;q32) translocation in an extranodal lymphoma. , 2000, Blood.

[13]  D. Smedley,et al.  Characterization of chromosome 1 abnormalities in malignant melanomas , 2000, Genes, chromosomes & cancer.

[14]  S. Jhanwar,et al.  MUC1 is activated in a B-cell lymphoma by the t(1;14)(q21;q32) translocation and is rearranged and amplified in B-cell lymphoma subsets. , 2000, Blood.

[15]  J R Siewert,et al.  Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. , 2000, The American journal of pathology.

[16]  B. Reid,et al.  p53-mutant clones and field effects in Barrett's esophagus. , 1999, Cancer research.

[17]  Carissa A. Sanchez,et al.  Evolution of neoplastic cell lineages in Barrett oesophagus , 1999, Nature Genetics.

[18]  M. Sobrinho-Simões,et al.  Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. , 1999, Cancer research.

[19]  J. Fraumeni,et al.  Changing patterns in the incidence of esophageal and gastric carcinoma in the United States , 1998, Cancer.

[20]  D. Persons,et al.  Interphase cytogenetics of esophageal adenocarcinoma and precursor lesions. , 1998, Cancer genetics and cytogenetics.

[21]  Kenneth K Wang,et al.  Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.

[22]  R. Sampliner,et al.  Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus , 1998, American Journal of Gastroenterology.

[23]  A. Cameron,et al.  Epidemiology of columnar-lined esophagus and adenocarcinoma. , 1997, Gastroenterology clinics of North America.

[24]  D. Levine Management of dysplasia in the columnar-lined esophagus. , 1997, Gastroenterology clinics of North America.

[25]  D. Crawford,et al.  A technique for the culture of Barrett's oesophageal cells , 1997, Journal of gastroenterology and hepatology.

[26]  F. Borchard,et al.  A new aspect of gastric metaplasia in Crohn's disease: Bidirectional (foveolar and pyloric) differentiation in so‐called ‘pyloric metaplasia’ in the ileum , 1997, Pathology international.

[27]  P. Roepstorff,et al.  Immunohistochemical study of MUC5AC expression in human gastric carcinomas using a novel monoclonal antibody , 1997, International journal of cancer.

[28]  F. Offner,et al.  Metaplastic columnar cells in Barrett's esophagus: a common and neglected cell type. , 1996, Human pathology.

[29]  A. Hagemeijer,et al.  Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia. , 1996, Cancer genetics and cytogenetics.

[30]  Carissa A. Sanchez,et al.  17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Ippoliti,et al.  The diagnosis of Barrett's esophagus: goblets, goblets, goblets. , 1996, Gastrointestinal endoscopy.

[32]  R. Goyal,et al.  The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. , 1996, Gastroenterology.

[33]  F. Mitelman ISCN 1995 : an international system for human cytogenetic nomenclature (1995) : recommendations of the International Standing Committee on Human Cytogenetic Nomenclature : Memphis, Tennessee, USA, October 9-13, 1994 , 1995 .

[34]  E. Furth,et al.  Barrett's Esophagus, Dysplasia, and Adenocarcinoma , 1995 .

[35]  Y. Kim,et al.  Mucin gene expression in normal, preneoplastic, and neoplastic human gastric epithelium. , 1995, Cancer research.

[36]  W. Hop,et al.  Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus. , 1995, Cancer research.

[37]  R. Haggitt,et al.  Barrett's esophagus, dysplasia, and adenocarcinoma. , 1994, Human pathology.

[38]  H. van Dekken,et al.  Detection of genetic changes in Barrett's adenocarcinoma and Barrett's esophagus by DNA in situ hybridization and immunohistochemistry. , 1994, Cytometry.

[39]  S. Hunter,et al.  Y chromosome loss in esophageal carcinoma: An in situ hybridization study , 1993, Genes, chromosomes & cancer.

[40]  D. Beer,et al.  Amplification and over‐expression of the EGFR and erbB‐2 genes in human esophageal adenocarcinomas , 1993, International journal of cancer.

[41]  D. Hopwood,et al.  Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis. , 1993, The American journal of gastroenterology.

[42]  F. Mitelman,et al.  Improved technique for short‐term culture and cytogenetic analysis of human breast cancer , 1992, Genes, chromosomes & cancer.

[43]  B. Reid,et al.  Persistent clonal areas and clonal expansion in Barrett's esophagus. , 1992, Cancer research.

[44]  M. Hendrix,et al.  Tissue culture of epithelial cells from esophageal specialized columnar epithelium (Barrett's esophagus) , 1992, Digestive Diseases and Sciences.

[45]  D. Ledbetter,et al.  Localization of the cellular retinoic acid binding protein (CRABP) gene relative to the acute promyelocytic leukemia-associated breakpoint on human chromosome 15 , 1991, Human Genetics.

[46]  J. Fraumeni,et al.  Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.

[47]  J. Trent,et al.  Chromosomal rearrangements in Barrett's esophagus. A premalignant lesion of esophageal adenocarcinoma. , 1989, Cancer genetics and cytogenetics.

[48]  R C Heading,et al.  Barrett's oesophagus. , 1987, British medical journal.

[49]  R. Goyal,et al.  The histologic spectrum of Barrett's esophagus. , 1976, The New England journal of medicine.

[50]  T. Hanaoka,et al.  Recent Advances in Diseases of the Esophagus , 1993, Springer Japan.

[51]  Iscn International System for Human Cytogenetic Nomenclature , 1978 .